The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
FRIDAY, Jan. 31, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain ...
Federal officials approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with ...
The drug, suzetrigine, made by Boston-based Vertex Pharmaceuticals and to be sold as Journavx, works only on nerves outside ...
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
Each year, about 125 million opioid prescriptions are written for Americans with pain caused by broken bones, burns, ...
Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but ...
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...
The unprecedented increase in drug overdose deaths in the United States, long believed to be driven by access to legal and ...
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to severe acute pain for adults.
It was given to people who had acute surgical pain from either abdominoplasty, also known as a tummy tuck, or bunion surgery.